Increased susceptibility of the c-Myc overexpressing cell line, SNU-16, to TNF-alpha

Cancer Letters

Volumn 125, Issue 1-2, 1998, Pages 17-23

  Park, In Chul ^a   Park, Myung Jin ^a,b   Lee, Seung Hoon ^a   Choe, Tae Boo ^b   Jang, Ja Jun ^c   Hong, Seok Il ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Konkuk University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Apoptosis; Bax; c myc; DNA fragmentation; p53; Programmed cell death; TNF

Indexed keywords

DNA FRAGMENT; OLIGONUCLEOTIDE; PROTEIN BAX; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; STOMACH CANCER; TIME;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; GENES, MYC; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032513179     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00450-3     Document Type: Article

References (23)

1. Brenner M.K. Annotation: tumor necrosis factor. Br. J. Haematol. 69:1988;149-152.
2. Opipari A.W., Hu H.M., Yabkowitz R., Dixit V.M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:1992;12424-12427.
3. Jaattela M., Wissing D., Bauer P.A., Li G.C. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J. 11:1992;3507-3512.
4. Wong G.H., Elwell J.H., Oberley L.W., Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
5. Chen M.J., Holskin B., Strickler J., Gorniak J., Clark M.A., Johnson P.J., Mitcho M., Shalloway D. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature. 330:1987;581-583.
6. Duerksen-Hughes P., Word W.S.M., Gooding L.R. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:1989;4193-4200.
7. Spenser C.A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1991;1-48.
8. Eilers M., Schirm S., Bishop J.M. The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10:1991;133-141.
9. Evan G.I., Wyllie A.H., Gilbert C.G., Littlewood T.D., Land H., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
10. Martin S.J., Lennon S.V., Bonham A.M., Cotter T.G. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145:1990;1859-1867.
11. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
12. Klefstrom J., Vastrik I., Saksela E., Valle U., Eilers M., Alitalo K. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-α EMBO J. 13:1994;5442-5450.
13. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo levels. FEBS Lett. 285:1991;199-212.
14. Larrick J.W., Wright S.C. Cytotoxic mechanism of tumor necrosis factor-α FASEB J. 4:1990;3215-3223.
15. Ramsay G., Evan G.I., Bishop J.M. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA. 81:1984;7742-7746.
16. Waters C.M., Littlewood T.D., Hancock D.C., Moore J.P., Evan G.I. c-myc protein expression in untransformed fibroblasts. Oncogene. 6:1991;797-805.
17. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
18. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
19. Yonish-Rouach E., Grunward D., Wilder S., Kimchi A., May E., Lawrencee J.J., May P., Oren M. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1993;1415-1423.
20. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
21. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
22. Kondo S., Barnett G.H., Hara H., Morimura T., Takeuchi J. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene. 10:1995;2001-2006.
23. Kim J.H., Takashi T., Itsuo C., Park J.G., Michael J.B., Roh J.K., Lee H.D., Kim J.P., John D.M., Adi F.G. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J. Natl. Cancer Inst. 83:1991;938-943.